Ketotifen fumarate salt
SIGMA/K2628
CAS Number: 34580-14-8
Empirical Formula (Hill Notation): C19H19NOS · C4H4O4
Molecular Weight: 425.50
EC Number: 252-100-0
MDL Number: MFCD00079394
Linear Formula: C19H19NOS · C4H4O4
Product Type: Chemical
| form | powder |
| InChI | 1S/C19H19NOS.C4H4O4/c1-20 |
| InChI key | YNQQEYBLVYAWNX-WLHGVMLRSA |
| originator | Novartis |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C=CC(O)=O.CN1CCC( |
| Application: | Ketotifen fumarate salt has been used: for mast cell product antagonism, as a positive control in β-hexosaminidase release assay, as mast cell stabilizer to treat pregnant dams added to ad libitum drinking water |
| Biochem/physiol Actions: | H1 histamine receptor antagonist. |
| Biochem/physiol Actions: | Ketotifen fumarate plays a key role in preventing histamine release by blocking the histamine H1 receptors. It interferes with the release of histamine, serotonin and other inflammatory mediators from mast cells. It exhibits with anti-allergic activity, anti-inflammatory effects including mast cell stabilization. It has been widely used for ophthalmic allergic conjunctivitis. |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Ketotifen fumarate salt is an antihistamine drug. |
| Packaging: | 1 g in glass bottle |
| Packaging: | 100 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H319 |
| Precautionary statements | P264 - P270 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| UNSPSC | 12352200 |


